These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 24644303)
1. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system. Hon CY; Teschke K; Demers PA; Venners S Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303 [TBL] [Abstract][Full Text] [Related]
2. Antineoplastic drug contamination in the urine of Canadian healthcare workers. Hon CY; Teschke K; Shen H; Demers PA; Venners S Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912 [TBL] [Abstract][Full Text] [Related]
3. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. Hon CY; Teschke K; Chu W; Demers P; Venners S J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810 [TBL] [Abstract][Full Text] [Related]
4. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning. Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485 [TBL] [Abstract][Full Text] [Related]
5. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals. Hedmer M; Wohlfart G J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549 [TBL] [Abstract][Full Text] [Related]
6. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs. Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872 [TBL] [Abstract][Full Text] [Related]
7. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696 [TBL] [Abstract][Full Text] [Related]
8. Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Hedmer M; Georgiadi A; Bremberg ER; Jönsson BA; Eksborg S Ann Occup Hyg; 2005 Oct; 49(7):629-37. PubMed ID: 16126760 [TBL] [Abstract][Full Text] [Related]
9. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota. Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938 [TBL] [Abstract][Full Text] [Related]
10. Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Hedmer M; Tinnerberg H; Axmon A; Jönsson BA Int Arch Occup Environ Health; 2008 Jul; 81(7):899-911. PubMed ID: 18066576 [TBL] [Abstract][Full Text] [Related]
11. Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel? Labrèche F; Ouellet C; Roberge B; Caron NJ; Yennek A; Bussières JF Int Arch Occup Environ Health; 2021 Nov; 94(8):1877-1888. PubMed ID: 34410477 [TBL] [Abstract][Full Text] [Related]
12. Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center. Acramel A; Fouque J; Blondeel-Gomes S; Huguet S; Rezai K; Madar O; Escalup L Ann Work Expo Health; 2022 Nov; 66(9):1215-1223. PubMed ID: 35596678 [TBL] [Abstract][Full Text] [Related]
13. A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Acampora A; Castiglia L; Miraglia N; Pieri M; Soave C; Liotti F; Sannolo N Ann Occup Hyg; 2005 Oct; 49(7):611-8. PubMed ID: 15964876 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs. Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784 [TBL] [Abstract][Full Text] [Related]
15. Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators. Crauste-Manciet S; Sessink PJ; Ferrari S; Jomier JY; Brossard D Ann Occup Hyg; 2005 Oct; 49(7):619-28. PubMed ID: 16126757 [TBL] [Abstract][Full Text] [Related]
16. Pilot Evaluation of Dermal Contamination by Antineoplastic Drugs among Hospital Pharmacy Personnel. Hon CY; Astrakianakis G; Danyluk Q; Chu W Can J Hosp Pharm; 2011 Sep; 64(5):327-32. PubMed ID: 22479084 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. Hedmer M; Jönsson BA; Nygren O J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047 [TBL] [Abstract][Full Text] [Related]
18. Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Minoia C; Turci R; Sottani C; Schiavi A; Perbellini L; Angeleri S; Draicchio F; Apostoli P Rapid Commun Mass Spectrom; 1998; 12(20):1485-93. PubMed ID: 9796535 [TBL] [Abstract][Full Text] [Related]
19. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling. Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739 [TBL] [Abstract][Full Text] [Related]
20. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]